GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (ASX:ACW) » Definitions » Price-to-Tangible-Book

Actinogen Medical (ASX:ACW) Price-to-Tangible-Book : 8.00 (As of Apr. 29, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Actinogen Medical Price-to-Tangible-Book?

As of today (2024-04-29), Actinogen Medical's share price is A$0.032. Actinogen Medical's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$0.00. Hence, Actinogen Medical's Price to Tangible Book Ratio of today is 8.00.

The historical rank and industry rank for Actinogen Medical's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Actinogen Medical's highest Price to Tangible Book Ratio was 15.61. The lowest was 0.94. And the median was 5.50.

ASX:ACW's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.65
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Actinogen Medical's share price is A$0.032. Actinogen Medical's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$0.01. Hence, Actinogen Medical's P/B Ratio of today is 6.40.


Actinogen Medical Price-to-Tangible-Book Historical Data

The historical data trend for Actinogen Medical's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical Price-to-Tangible-Book Chart

Actinogen Medical Annual Data
Trend Jun13 Jun14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.94 3.45 15.61 4.80 6.40

Actinogen Medical Semi-Annual Data
Dec13 Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.81 4.80 13.72 6.40 5.50

Competitive Comparison of Actinogen Medical's Price-to-Tangible-Book

For the Biotechnology subindustry, Actinogen Medical's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Actinogen Medical's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actinogen Medical's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Actinogen Medical's Price-to-Tangible-Book falls into.



Actinogen Medical Price-to-Tangible-Book Calculation

Actinogen Medical's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=0.032/0.004
=8.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Actinogen Medical Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Actinogen Medical (ASX:ACW) Business Description

Traded in Other Exchanges
Address
109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. Geographically, it operates and derives revenue from Australia. It has developed a product Xanamem.

Actinogen Medical (ASX:ACW) Headlines

From GuruFocus

Accuride Corporation: Earnings Report For Q2 2014

By Black Iguana Nitish 10-13-2014

Stocks That Are Making A Good Come Back

By reports.droy reports.droy 03-10-2015